type 1 diabetes

As far as you know, are there any other promising medication or methods that might prevent type 1 diabetes?

It's worth remembering that this approach will not be suitable for those who have had Type 1 diabetes for some time.

Currently, most people with type 1 diabetes have to prick their fingers up to a dozen times a day to assess their blood sugar levels.

The presence of osteoporosis in type 1 diabetes seems to be a reliable evidence.

In labile type 1 diabetes, it is often most effective given as two daily injections.

The other sort of diabetes, Type 1, is not linked to obesity and usually develops in childhood or adolescence.

By our logistic regression analysis, the age of pregnancy might be associated with type 1 diabetes.

It has been attested by all medical researchers that type I diabetes is caused due to breakdown in the immune system of the body.

INTERPRETATION: Supplementation with vitamins C and E did not reduce risk of pre-eclampsia in women with type 1 diabetes.

The researchers have inferred that a malfunctioning immune system is not the only culprit responsible for triggering of Type 1 Diabetes.

If the person already has type 1 diabetes, and ifyou put him on a healthy vegan diet, that will reduce the likelihood ofcomplications.

Previous studies have suggested stem cell therapy might be a promising approach for type 1 diabetes.

Islet transplantation has already been able to maintain long-term euglycemia and non insulin-dependence in patients with Type 1 Diabetes.

Initial management and education for pediatric patients with newly diagnosed type 1 diabetes is now moving to the outpatient setting.

I've had three kidney transplants, a pancreas transplant, 27 years of Type 1 diabetes, and four-plus years of metastasizing cancer.

In type 1 diabetes, these cells are attacked and destroyed by the body's immune system gone awry.

The doctor said I had type 1 diabetes, but I had no idea what that meant. The first thing I asked her was, "Am I going to die? "

and study population consisting of predominantly white clinical trial participants with type 1 diabetes, limiting generalizability.

Its clinical manifestations are different from those of autoimmune type 1 diabetes, without obvious evidence of autoimmunity.

However, it's not yet clear if the self-destructive nature of Type 1 diabetes will be a problem.

Type 1 diabetes is an autoimmune disease -- one in which the immune system mistakenly attacks healthy tissue.

The rising incidence of Type 1 diabetes may be due, in part, to the current practice of protecting the young from sun exposure.

Type 1 diabetes used to be called childhood onset.

Poorly controlled diabetes may occur because caregivers of children with type 1 diabetes fail to comprehend provided diabetes education.

Conclusions: Compared with conventional therapy, intensive diabetes management is associated with lower RHR in type 1 diabetes.

Scientists have tried a number of means to cure Type 1 diabetes by giving patients with the disease new insulin-producing cells.

Living Cell Technologies Ltd (LCT) wants to transfer cells from the pancreas of pigs to produce insulin in type-1 diabetes sufferers.

He had been enrolled at birth in a University of Colorado study looking for markers for Type 1 diabetes in umbilical cord blood.

Symptoms of type 1 diabetes usually develop over a short period, although beta cell destruction can begin years earlier.

This rapid decline of insulin production occurs in people with Type 1 diabetes due to an auto-immune response.

Vitamin D deficiency was not increased in type 1 diabetes, but was associated with presence and initiation of CAC formation.

Background The immunopathogenesis of type 1 diabetes mellitus is associated with T-lymphocyte autoimmunity.

Many countries are documenting higher numbers of newly diagnosed cases of type 1 diabetes, particularly in younger children.

Subjects were taken from the Diabetes Prevention Trial-Type 1, who were previously screened for islet cell autoantibodies (ICAs).

Frequent tests are essential for people with type 1 diabetes, who can't produce the hormone insulin, needed to control blood sugar levels.

Title: Comparison of insulin detemir and insulin glargine in subjects with Type 1 diabetes using intensive insulin therapy.

Type 1 diabetes is one of the fastest growing diseases in the world.

Children at risk of developing type 1 diabetes have antibodies in their blood which attack these insulin-producing cells.

The exact cause of type 1 diabetes isn't known, but researchers believe a combination of genetics and environmental factors are to blame.

Symptoms may be similar to those of Type 1 diabetes, but are often less marked.

Combined assay of multiple autoantibodies may enhance the positivity of early diagnosis of type 1 diabetes mellitus.

The condition is commonly associated with Type 1 diabetes, when the patients inject too much insulin, miss a meal or drink alcohol.

We aimed to assess whether supplementation with vitamins C and E reduced incidence of pre-eclampsia in women with type 1 diabetes.

In type 1 diabetes, certain cells in the pancreas gradually get worse at producing insulin, leading to insulin deficiency.

Immune tolerance therapies are also being investigated for use as early interventions for type 1 diabetes.

About 10% of these develop diabetes in early life, and most of them have what is known as type 1 diabetes.

Infectious agents, like viruses, have been suspected to cause type 1 diabetes.

Conclusions: A genetic susceptibility to both type 1 diabetes and celiac disease shares common alleles.

But, if you haveidentical twins and one has Type 1 diabetes, the chances of the other one hasdiabetes is only about 40%.

Among them, 5 were confirmed to have type 2 diabetes mellitus, and one had impaired glucose tolerance.

When you develop Type 1 diabetes, however, your immune system gets confused and destroys the insulin-producing cells.

This research holds promise in timely detection of onset of diabetes, Type 1, which may help in nipping the illness in the bud.

Giving children vitamin D supplements in infancy may shear their risk of developing type 1 diabetes later in life.

But such diseases are still relatively rare in Africa and rural Asia, as are Type 1 diabetes and multiple sclerosis.

BYETTA is not for people with type 1 diabetes or people with diabetic ketoacidosis.

In Type 1 diabetes, the pancreas doesn't produce enough insulin to promote absorbtion of sugar molecules into the bloodstream.

Lower extremity complications are a frequent occurrence in individuals with type 1 and type 2 diabetes.

In studies of mice, we showed that high doses could suppress autoimmune type 1 diabetes and encephalitis.

Increased levels of antibodies to these cow-milk proteins are found in children with type 1 diabetes.

Patients with type 1 diabetes mellitus are predisposed to getting ketoacidosis.

Satisfaction and quality of life with premeal inhaled versus injected insulin in adolescents and adults with type 1 diabetes.

Methods: 85 cases of diabetes type 2 had been receiving health education through network management for 1 year.

It is a big step towards something that looks really promising in terms of future therapy for type 1 diabetes.

to test new drugs and therapies that could treat or cure patients with type 1 diabetes, and may even lead to an artificial pancreas one day.

NICE has not recommended inhaled insulin for the routine treatment of type 1 or 2 diabetes.

The dairy industry makes attempts to argue against their products causing type 1 diabetes.

Rapid, unequivocal diagnosis of diabetes is essential to avoid the onset of complications in both type 1 and type 2 diabetes.

In the studied done, laboratory mice were used that were already susceptible to Type 1 diabetes.

The study did not differentiate between type 1 and type 2 diabetes.

By increasing levels of GLP-1 the medicine could improve the imbalance between insulin and glucose that causes type 2 diabetes.

However, mIAA is less predictive of type 1 diabetes than other autoantibodies.

Type 1 diabetes hardens small blood vessels and is the leading cause of blindness, kidney failure, stroke and loss of limbs.

Elevated levels of high-molecular-weight adiponectin in type 1 diabetes.

The cause of type 1 diabetes is not known and it is not preventable with current knowledge.

Antibodies to insulin often appear in children who develop type 1 diabetes.

NICE has issued guidance to the NHS in England and Wales on the use of inhaled insulin for the treatment of diabetes (type 1 and 2).

There's one nano-engineered device that cures type 1 diabetes. It's blood-cell sized.

Type 1 diabetes is an autoimmune disease.

Type 1 diabetes accounts for about 5 to 10 percent of diagnosed diabetes in the United States.

Their onset is not as sudden as in type 1 diabetes.

Similar to human insulin, insulin glargine is used to control blood sugar in people with Type 1 and Type 2 diabetes.

Time for Testing Incretin Therapies in Early Type 1 Diabetes?

This phase 2 study evaluated the role of B-lymphocyte depletion in patients with type 1 diabetes.

People with type 1 diabetes don't have a normal functioning pancreas to regulate blood sugar levels with insulin.

They found these antibodies in 100% of thechildren. Every single child diagnosed with Type 1 diabetes had them.

BYETTA is the first FDA-approved GLP-1 receptor agonist for the treatment of type 2 diabetes.

According to recent study, type 1 and type 2 diabetes mellitus patients are identical in the frequency and magnitude of dawn phenomenon.

The research, led by Professor Chris Toumazou at Imperial College London, aims to develop a better treatment for type 1 diabetes.

Defects in glucagon-like peptide 1 (GLP-1) secretion have been reported in some patients with type 2 diabetes after meal ingestion.

People with type 1 diabetes have an absolute reliance upon insulin treatment for their continued health and well-being.

The reason this is important is that people with type 1 diabetes have to try to maintain as normal blood sugar levels as possible.

Our data also support a role of ET-1 for the increased MAPK activity seen in non stimulated type 2 diabetes MVEC.

Type 1 diabetes develops because the immune system attacks insulin producing beta cells in the pancreas.

You're sure it's Type One diabetes you've got?

ObjectiveTo study the effect of Tongluo recipe on leptin and insulin in rat model of type 1 diabetes mellitus.

abstract: Objective To investigate the expression of HCN2 and HCN4 in the left ventricles of type 1 diabetes rat.

In patients with type 2 diabetes, renal lesions are heterogeneous and more complex than in individuals with type 1 diabetes.

So, does that mean that if we avoidgiving cow's milk to kids, we could cut down the prevalence of Type 1 diabetes?

When newborn infants in Finland were given 2, 000 international units a day, Type 1 diabetes fell by 88 percent, Dr. Holick said.

A person who has type 1 diabetes must take insulin daily to live.

Type 1 diabetes means the insulin is gone. Well, what happenedto it?

The boy's body was flooded with sugar; he had Type 1 diabetes.

Several proteins are associated with development of Type-1 diabetes, in particular insulin and glutamic acid decarboxylase 65 (GAD65).

If you have type 1 diabetes, pregnancy will affect your insulin treatment plan.

Metformin is a widely used drug for the treatment of type 2 diabetes (1, 2).

Note: (1) a large-scale use, can lead to diabetes and type of Cushing's syndrome.

Autoimmune disorders, such as type 1 diabetes and multiple sclerosis.

Color doppler check 178 patients of type 2 diabetes show: 55. 1% patients get arteriosclerosis obliterans(ASO).

The study, reported in the medical journal Diabetes Care, involved 652 women with type 1 diabetes.

It is used in both type 1 and type 2 diabetes, usually as a single daily dose.

Currently, there is no known way to prevent type 1 diabetes.

If you have Type 1 diabetes, people close to you should learn how to give a glucagon shot.

There are researchers who now believe that one of the bigtriggers for type 1 diabetes is diary products.

Over 1. 6 million Americans have type 1 diabetes.

We want to target Type 1 diabetes.

During that time, 1, 173 developed type 2 diabetes and 327 developed coronary heart disease (the latter verified by angiogram).

Type 1 diabetes, for example, is much rarer in countries like Cuba than in either New Zealand and Sweden.

Polymorphism of plasminogen activator inhibitor-1 gene in the children of elderly patients with type 2 diabetes mellitus

Alteration and significance of telomere length of peripheral white blood cells in patients with type 1 diabetes mellitus

Landmark study of islet transplantation reveals potential benefits in uncontrolled type 1 diabetes

Urinary Ceruloplasmin Screening in the Early Detection of Diabetic Nephropathy in Children and Adolescents with Type 1 Diabetes

Age of onset of type 1 diabetes in children and carotid intima medial thickness

Clinical significance of relative antibodies detection for type 1 diabetes patient and its prevention

Contribution of transporter associated with antigen processing gene polymorphism to predisposition to type 1 diabetes: a preliminary study

Clinical characteristics and diagnostic points of idiopathic type 1 diabetes and its subtypes

Children and adolescents with type 1 diabetes eat a more atherosclerosis-prone diet than healthy control subjects

Study of association between type 2 diabetes mellitus complicating hypertension and insulin-like growth factor-1

Combined kidney and pancreatic transplantation Ideal for patients with uncomplicated type 1 diabetes and chronic renal failure

Clinical Practice of Continuous Subcutaneous Insulin Infusion on Type 1 Diabetes Mellitus in Children and Adolescents

Investigation of pathogenesis of diabetic myopathy of skeletal muscle in experimental type 1 diabetes mellitus of tree shrews

A molecular epidemiological study of type 1 diabetes mellitus

Clinical and immunological characteristics in rapid-onset type 1 diabetes with hyperamylasemia

Significance of combined determination of three autoantibodies in predictive of type 1 diabetes mellitus

The Polymorphisms of Transporter Associated with Antigen Processing Genes among Type 1 Diabetes Mellitus

Treatment of children 1-type diabetes mellitus using continuous subcutaneous Insulin infusion

Early atherosclerosis in childhood type 1 diabetes: role of raised systolic blood pressure in the absence of dyslipidaemia

Correlation Between Combined Determination of Autoantibodies of Pancreas Islet and Type 1 Diabetes

Clinical significance of continuous glucose monitoring in children with type 1 diabetes mellitus

Cholesterol metabolism and non-cholesterol sterol distribution in lipoproteins of type 1 diabetes: The effect of improved glycemic control

Etiological dissection in common anti-islet autoantibody-negative patients with type 1 diabetes

Ascertained and corrected incidence rate of type 1 diabetes mellitus

Clinical Observation on the Treatment of Type 1 Diabetes with Islet Xenotransplantation

Relationship between circulating vascular cell adhesion molecule-1 and vascular complications in type 2 diabetes mellitus

An animal study on the preventive intervention for decreasing the incidence of type 1 diabetes mellitus

Establishment and evaluation of experimental macaques type 1 diabetes model

Significance of combined determination of GADA and ICA in early diagnosis of type 1 diabetes mellitus

Study on the correlation between type 1 diabetes in Chinese Miao population and HLA-DR genetic frequency

Risk- factor analysis of behavioral problems in children and adolescents with type 1 diabetes

Interventional effect of extraction A from polygonatum odoratum on the immunity of mice with type 1 diabetes

Research on Immune Mechanism and Immune Intervention of Type 1 Diabetes Mellitus in Children

Analysis of behavioral problems among children and adolescents with type 1 diabetes

Analysis of Clinical Characters of Type 1 Diabetes Mellitus with Different Serum Potassium Levels in 175 Children and Adolescent

The Relationship among Polymorphism of Promotor of PAl-1 Gene, Type 2 Diabetes Mellitus, Hypertension and Coronary Heart Disease

Association between Intercellular Adhesion Molecule-1 and Type 2 Diabetes Macroangiopathy

Effects of glipizide and metformin on serum insulin-like growth factor binding proteins-1 level in patients with type 2 diabetes mellitus

Relativity between monocyte chemoattractant protein-1 gene polymorphism and type 2 diabetes mellitus

Cytokines profile of different durations in type 1 diabetes mellitus patients

Correlation between plasma matrix metalloproteinase-1 and insulin resistance in patients with type 2 diabetes

Etiology of recurrent diabetes ketoacidosis in children with type 1 diabetes

The clinical importance of the diagnosis and identification of idiopathic type 1 diabetes mellitus

Changes of Th lymphocytes and their cytokines in patients with type 1 diabetes mellitus

Diagnosis and treatment routines for childhood type 1 diabetes mellitus

Correlation of Membrane Glycoprotein PC-1 Gene Polymorphism with Type 2 Diabetes Mellitus and Insulin Resistance

The relationship between circulating vascular cell adhesion molecule-1 and heart rate variability in type 2 diabetes

The evaluation of glycemic control and microvascular complications in adolescents with type 1 diabetes

Effect of Pioglitazone Hydrochloride on Soluble Vascular Cell Adhesion Molecule-1 in Patients with Type 2 Diabetes Mellitus

Relationship between Point Mutations of Mitochondrial DNA ND 1 and Type 2 Diabetes Mellitus in Han Nationality of Tianjin

Gene polymorphism of insulin receptor substrate-1 in Northern Chinese Han pedigrees with type 2 diabetes mellitus

The relationship between paraoxonase-1 activity and type 2 diabetes mellitus retinopathy in the elderly

Development of prevention and delay of type 1 diabetes mellitus: update of clinic intervention study

A Study on the Relation between Paraoxonase 1 and Type 2 Diabetes Mellitus with Vascular Complications in the Elderly

Study on insulin dosage adjustment and related indexes in different period of type 1 diabetes mellitus in children

Effect of continuous subcutaneous insulin infusion on type 1 diabetes

Economic Burdens of Childhood Type 1 Diabetes Mellitus in Shanghai

Caffeine May Reduce Nocturnal Hypoglycemia in Type 1 Diabetes

The effects of paraoxonase-1 and oxidized low density lipoprotein on nephropathy in type-2 diabetes mellitus

Ventricular Hypertrophy Appears Early in Type 1 Diabetes

Progress of Early Screening in Prevention of Type 1 Diabetes Mellitus

My favorite search is for "diabetes type 1" , so I keyed that into both search engines

The Risk Factor Analysis to Children with Type 1 Diabetes Mellitus in Harbin

Advancement of Diagnose and Therapy in Children with Type 1 Diabetes

Clinical Characteristics of 109 Children with Newly Diagnosed as Type 1 Diabetes Mellitus

Correlation between polymorphism of sulfonylurea receptor 1 gene and type 2 diabetes

Diagnosis and Treatment of Type 1 Diabetes Mellitus in Children

Effect of irbestartan on serum monocyte chemoattractant protein-1 in patients with nephropathy due to type 2 diabetes

Advancements of stem-cell therapy for type 1 diabetes mellitus

On the Relative Factors of Paraoxonase 1 and Type 2 Diabetes Mellitus with Coronary Artery Disease

A study on the prevention of type 1 diabetes in NOD mice by Pentoxifylline

The changes of some cytokines in the newly-diagnosed patients of type 1 diabetes mellitus

Type 1 diabetes and latent autoimmune diabetes in adults

Personality Traits of Children with Type 1 Diabetes

Association between Serum IL-18 Level and Cytokine in Type 1 Diabetes Mellitus in Children

Reduced igfbp-1 is associated with left ventricular hypertrophy in type 2 diabetes

Study on relationship between paraoxonase-1 and type 2 diabetes mellitus in the elderly

Clinical analysis of 12 cases with type 1 diabetes and autoimmune thyroid disease

The Effect of Insulin Aspart on the Metabolic Changes of Children with Type 1 Diabetes

Antioxidative vitamins reduce serum level of soluble vascular cell adhesion molecules-1 in type 2 diabetes

People with type 1 diabetes require insulin;

A study on the mutation of insulin receptorsubstrate-1 gene in Chinese patients with type 2 diabetes mellitus

Effect of PC-1 Gene Polymorphism on Insulin Resistance in Type 2 Diabetes Patients

Effect of Pentoxifylline on type 1 diabetes in NOD mice

Type 1 diabetes mellitus and sudden death

New genes associated with type 1 diabetes

The effects of insulin on type 1 diabetes in NOD mouse

Study on the mtDNA Mutations in Type 1 Diabetes

Type 1 Diabetes - From Genes to Dreams

Clinical analysis on 28 cases of children with type 1 diabetes

Effects of interleukin-10 gene on the incidence of type 1 diabetes in nonobese diabetic mice

Good news to sufferers of type 1 diabetes

New Ways for Treatment of Type 1 Diabetes

Guide on Diagnosis of Type 1 Diabetes

Association of PAI-1 gene polymorphisms with the femoral artery intima-media thickness in patients with type 2 diabetes

The association of ND-1 gene point mutations of mitochondrial DNA with type 2 diabetes mellitus

for example , we know that in type 1 diabetes , metabolic control can reduce the risk of microvascular complications